224 research outputs found
Plasma-arc-flow technology for sustainable treatment of high-impact fluid waste. A graphene-based material for industrial-wastewater purification
The research presented aimed to address the treatment of fluid waste with significant environmental impact by utilizing plasma technology, specifically plasma arc flow (PAF). The goal was to develop a novel purification material based on graphene for industrial applications and to optimize the treatment process. Analysis and monitoring of a submerged arc plasma reactor were the main goals of this research. This entailed a careful examination of the incoming wastewater that needed to be treated with the goal of identifying its precise composition characteristics with the relative tolerances needed for the reactions that were to follow in the reactor. The focus of the analysis was on input-parameter optimization, production of characteristic curves, and analysis of the factors affecting hydrogen evolution in syngas. Additionally, the study investigated how to determine the best viscosity for a particular input matrix by carrying out an evaluation study. The effects of this parameter were thought to be reduced by preheating the incoming wastewater through heat recovery. The long-term objective of the research is to create filters that can purify the water used and produced in gasification processes as well as to characterize the fixed reside from the gasifier for potential conversion into graphene-based material. In addition, this work acknowledges that additional experiments are required to validate its purifying capacity on wastewater produced by various industrial processes. Moreover, the inclusion of plans to model the evolution of hydrogen in PAF using the CHEMCAD software® and defining guidelines for optimizing parameters for enhanced energy efficiency showcased the research’s ambition to expand and refine its scope. Finding the best plant solutions that can significantly reduce electricity consumption is the ultimate goal. In summary, the study demonstrated significant advancement in the analysis and optimization of fluid-waste treatment with high environmental impact through the use of plasma technology, specifically PAF. A thorough and forward-looking approach was demonstrated by the use of modeling software, experimental studies, and plans for future research. The potential creation of graphene-based filters and the use of the fixed residue as a useful material further highlight the innovativeness of this research
Cooperation in a transboundary river basin: a large-scale socio-hydrological model of the Eastern Nile
While conflict-and-cooperation phenomena in transboundary basins have been widely studied, much less work has been devoted to representing the process interactions in a quantitative way. This paper identifies the main factors in the riparian countries' willingness to cooperate in the Eastern Nile River basin, involving Ethiopia, Sudan, and Egypt, from 1983 to 2016. We propose a quantitative model of the willingness to cooperate at the national and river basin scales. Our results suggest that relative political stability and foreign direct investment can explain Ethiopia's decreasing willingness to cooperate between 2009 and 2016. Further, we show that the 2008 food crisis may account for Sudan recovering its willingness to cooperate with Ethiopia. Long-term lack of trust among the riparian countries may have reduced basin-wide cooperation. While the proposed model has some limitations regarding model assumptions and parameters, it does provide a quantitative representation of the evolution of cooperation pathways among the riparian countries, which can be used to explore the effects of changes in future dam operation and other management decisions on the emergence of conflict and cooperation in the basin
Practical support for evaluating efficiency factors of a space heating system in cold climates
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
BACKGROUND: Dermatomyositis (DM) is an autoimmune disease that mainly affects the skin, muscle, and lung. The pathogenesis of skin inflammation in DM is not well understood. METHODOLOGY AND FINDINGS: We analyzed genome-wide expression data in DM skin and compared them to those from healthy controls. We observed a robust upregulation of interferon (IFN)-inducible genes in DM skin, as well as several other gene modules pertaining to inflammation, complement activation, and epidermal activation and differentiation. The interferon (IFN)-inducible genes within the DM signature were present not only in DM and lupus, but also cutaneous herpes simplex-2 infection and to a lesser degree, psoriasis. This IFN signature was absent or weakly present in atopic dermatitis, allergic contact dermatitis, acne vulgaris, systemic sclerosis, and localized scleroderma/morphea. We observed that the IFN signature in DM skin appears to be more closely related to type I than type II IFN based on in vitro IFN stimulation expression signatures. However, quantitation of IFN mRNAs in DM skin shows that the majority of known type I IFNs, as well as IFN g, are overexpressed in DM skin. In addition, both IFN-beta and IFN-gamma (but not other type I IFN) transcript levels were highly correlated with the degree of the in vivo IFN transcriptional response in DM skin. CONCLUSIONS AND SIGNIFICANCE: As in the blood and muscle, DM skin is characterized by an overwhelming presence of an IFN signature, although it is difficult to conclusively define this response as type I or type II. Understanding the significance of the IFN signature in this wide array of inflammatory diseases will be furthered by identification of the nature of the cells that both produce and respond to IFN, as well as which IFN subtype is biologically active in each diseased tissue
Pre- and early-postnatal nutrition modify gene and protein expressions of muscle energy metabolism markers and phospholipid fatty acid composition in a muscle type specific manner in sheep.
We previously reported that undernutrition in late fetal life reduced whole-body insulin sensitivity in adult sheep, irrespective of dietary exposure in early postnatal life. Skeletal muscle may play an important role in control of insulin action. We therefore studied a range of putative key muscle determinants of insulin signalling in two types of skeletal muscles (longissimus dorsi (LD) and biceps femoris (BF)) and in the cardiac muscle (ventriculus sinister cordis (VSC)) of sheep from the same experiment. Twin-bearing ewes were fed either 100% (NORM) or 50% (LOW) of their energy and protein requirements during the last trimester of gestation. From day-3 postpartum to 6-months of age (around puberty), twin offspring received a high-carbohydrate-high-fat (HCHF) or a moderate-conventional (CONV) diet, whereafter all males were slaughtered. Females were subsequently raised on a moderate diet and slaughtered at 2-years of age (young adults). The only long-term consequences of fetal undernutrition observed in adult offspring were lower expressions of the insulin responsive glucose transporter 4 (GLUT4) protein and peroxisome proliferator-activated receptor gamma, coactivator 1α (PGC1α) mRNA in BF, but increased PGC1α expression in VSC. Interestingly, the HCHF diet in early postnatal life was associated with somewhat paradoxically increased expressions in LD of a range of genes (but not proteins) related to glucose uptake, insulin signalling and fatty acid oxidation. Except for fatty acid oxidation genes, these changes persisted into adulthood. No persistent expression changes were observed in BF and VSC. The HCHF diet increased phospholipid ratios of n-6/n-3 polyunsaturated fatty acids in all muscles, even in adults fed identical diets for 1½ years. In conclusion, early postnatal, but not late gestation, nutrition had long-term consequences for a number of determinants of insulin action and metabolism in LD. Tissues other than muscle may account for reduced whole body insulin sensitivity in adult LOW sheep
Experimental study on green electrical discharge machining in tap water of Ti–6Al–4V and parameters optimization
Polydatin, a natural precursor of resveratrol, induces β-Defensin production and reduces inflammatory response.
Interleukin-17 (IL-17) is a proinflammatory cytokine produced, although not exclusively, by T helper 17 recently identified as a distinct T helper lineage mediating tissue inflammation. IL-17 is known to be involved in a number of chronic disorders although the mechanisms regulating its production in inflammatory disease are still unclear. The beneficial properties of the polyphenolic compound resveratrol including its anti-inflammatory, antioxidant, and antitumor effects, its role in the aging process and in the prevention of heart and neurodegenerative diseases are well-known. In addition, derivatives of resveratrol, including glucosylated molecules as polydatin have been linked to similar beneficial effects. We have investigated the effects of resveratrol and polydatin on the in vitro production of IL-17 in a model of inflammation in vitro. The results obtained by activated human peripheral blood mononuclear cells, stimulated with anti-CD3/anti-CD28 monoclonal antibodies and treated with these polyphenolic compounds at different concentrations show that both decrease IL-17 production in a concentration-dependent manner. This study confirms the anti-inflammatory activity of resveratrol and its derivatives and suggests a potential clinical relevance in the therapy of inflammatory diseases
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Background and purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year.
Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020).
Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths.
Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT
Content-aware downlink scheduling for LTE wireless systems : a survey and performance comparison of key approaches
- …